Simplex Trading
RPRX icon

Simplex Trading’s Royalty Pharma RPRX Stock Holding History

Simplex Trading’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2M Buy
41,600
+26,600
+177% +$1.16M ﹤0.01% 1820
2025
Q4 		$580K Buy
15,000
+9,900
+194% +$378K ﹤0.01% 3158
2025
Q3 		$179K Sell
5,100
-25,600
-83% -$927K ﹤0.01% 5077
2025
Q2 		$1.11M Buy
30,700
+8,800
+40% +$292K ﹤0.01% 2681
2025
Q1 		$681K Buy
21,900
+14,200
+184% +$450K ﹤0.01% 3065
2024
Q4 		$196K Buy
7,700
+3,400
+79% +$90.2K ﹤0.01% 4539
2024
Q3 		$121K Sell
4,300
-16,400
-79% -$454K ﹤0.01% 5041
2024
Q2 		$545K Sell
20,700
-57,400
-73% -$1.59M ﹤0.01% 3578
2024
Q1 		$2.37M Sell
78,100
-97,500
-56% -$2.87M ﹤0.01% 2242
2023
Q4 		$4.93M Sell
175,600
-7,000
-4% -$192K ﹤0.01% 1561
2023
Q3 		$4.96M Buy
182,600
+106,000
+138% +$3.15M ﹤0.01% 1360
2023
Q2 		$2.35M Buy
76,600
+43,400
+131% +$1.47M ﹤0.01% 1848
2023
Q1 		$1.2M Sell
33,200
-3,300
-9% -$122K ﹤0.01% 2427
2022
Q4 		$1.44M Buy
36,500
+2,900
+9% +$121K ﹤0.01% 2130
2022
Q3 		$1.35M Buy
33,600
+23,300
+226% +$995K ﹤0.01% 2328
2022
Q2 		$433K Buy
10,300
+2,200
+27% +$90.2K ﹤0.01% 3622
2022
Q1 		$315K Sell
8,100
-38,100
-82% -$1.5M ﹤0.01% 4480
2021
Q4 		$1.84M Buy
46,200
+31,600
+216% +$1.23M ﹤0.01% 2131
2021
Q3 		$616K Hold
14,600
– – ﹤0.01% 3777
2021
Q2 		$598K Buy
14,600
+14,549
+28,527% +$619K ﹤0.01% 3885
2021
Q1 		$222K Sell
51
-89
-64% -$4.22K ﹤0.01% 4595
2020
Q4 		$700K Buy
140
+83
+146% +$3.52K ﹤0.01% 3003
2020
Q3 		$239K Buy
+57
New +$2.45K ﹤0.01% 3883

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Simplex Trading's RPRX Position: Q1 2026 in Review

Simplex Trading sold out of Royalty Pharma (RPRX) in Q1 2026, closing a stake of 9,109 shares — an estimated $399K sold.

Simplex Trading first reported a position in RPRX in Q2 2020 and held it in 11 quarters. The position peaked at $1.29M in Q3 2023. 587 funds tracked by Wall St. Rank hold RPRX as of Q1 2026.

  • Simplex Trading reported no remaining Royalty Pharma position as of Q1 2026 after selling out during the quarter.
  • Simplex Trading sold 9,109 Royalty Pharma shares in Q1 2026, an estimated $399K.
  • Simplex Trading first reported a position in Royalty Pharma in Q2 2020 and held it in 11 quarters.
  • Simplex Trading's Royalty Pharma position peaked at $1.29M in Q3 2023.
  • 587 funds tracked by Wall St. Rank held Royalty Pharma as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.